|
|
| | Piperazine Erastin Basic information |
| Product Name: | Piperazine Erastin | | Synonyms: | Piperazine Erastin;4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[2-(1-methylethoxy)-5-(1-piperazinylmethyl)phenyl]- | | CAS: | 1538593-71-3 | | MF: | C35H41ClN6O4 | | MW: | 645.19 | | EINECS: | | | Product Categories: | | | Mol File: | 1538593-71-3.mol |  |
| | Piperazine Erastin Chemical Properties |
| Boiling point | 811.2±75.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: insol; DMSO: 10 mg/ml; Ethanol: insol; PBS (pH 7.2): insol | | form | A solid | | pka | 9.12±0.10(Predicted) |
| | Piperazine Erastin Usage And Synthesis |
| Description | Piperazine-Erastin is an erastin derivative. It acts by inducing ferroptosis in cancer cells. |
| | Piperazine Erastin Preparation Products And Raw materials |
|